scispace - formally typeset
M

Mark S. Carter

Researcher at University of Texas MD Anderson Cancer Center

Publications -  6
Citations -  822

Mark S. Carter is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Intron & RNA splicing. The author has an hindex of 6, co-authored 6 publications receiving 802 citations. Previous affiliations of Mark S. Carter include Vollum Institute.

Papers
More filters
Journal ArticleDOI

A Regulatory Mechanism That Detects Premature Nonsense Codons in T-cell Receptor Transcripts in Vivo Is Reversed by Protein Synthesis Inhibitors in Vitro

TL;DR: In this paper, the authors performed sequence analysis of reverse transcriptase-polymerase chain reaction products from fetal and adult thymus and found that newly transcribed T-cell receptor-β pre-mRNAs (intron-bearing) are frequently derived from ptc-bearing genes but such transcripts rarely accumulate as mature (fully spliced) TCR-β transcripts.
Journal ArticleDOI

A splicing-dependent regulatory mechanism that detects translation signals.

TL;DR: The results suggest that nonsense codon recognition may occur in the nucleus, as well as examining the molecular mechanism for this putative nuclear response by using the T‐cell receptor‐beta gene, which acquires PTCs as a result of programmed rearrangements that occur during normal thymic ontogeny.
Journal ArticleDOI

Alternatively Spliced TCR mRNA Induced by Disruption of Reading Frame

TL;DR: It is shown that the T cell receptor–β (TCRβ) gene gives rise to an alternatively spliced transcript that skips the offending mutations that generate such nonsense codons, and this alt-mRNA is up-regulated by a transfer RNA–dependent scanning mechanism that responds specifically to mutations that disrupt the reading frame.
Journal ArticleDOI

A spliced intron accumulates as a lariat in the nucleus of T cells

TL;DR: An unusual spliced intron from the constant region of the T cell receptor-beta (TCR-beta) locus is described that is relatively stable in mammalian cells and accumulates as a set of lariat RNA structures in the nucleus of T cells.
Journal ArticleDOI

T cell receptor-beta mRNA splicing: regulation of unusual splicing intermediates.

TL;DR: A repressional mechanism involving a labile repressor protein may be responsible for the inhibition of RNA splicing since treatment of SL12.4 cells with the protein synthesis inhibitor cycloheximide reversibly induces a rapid and dramatic accumulation of fully spliced T CR-beta transcripts in the cytoplasm, concomitant with a decline in TCR-beta pre-mRNAs in the nucleus.